Package 16571-245-03

Brand: itraconazole

Generic: itraconazole
NDC Package

Package Facts

Identity

Package NDC 16571-245-03
Digits Only 1657124503
Product NDC 16571-245
Product ID 16571-245_c7336946-9638-4837-9046-1aef77694672
Description

30 CAPSULE in 1 BOTTLE (16571-245-03)

Marketing

Marketing Status
Marketed Since 2025-02-03
Brand itraconazole
Generic itraconazole
Sample Package No

Linked Drug Pages (1)

Itraconazole ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c7336946-9638-4837-9046-1aef77694672", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000185503", "N0000190113"], "upc": ["0316571245031"], "unii": ["304NUG5GF4"], "rxcui": ["311204"], "spl_set_id": ["6df5ff94-47ba-4881-abb4-b321e35a6955"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (16571-245-03)", "package_ndc": "16571-245-03", "marketing_start_date": "20250203"}], "brand_name": "Itraconazole", "product_id": "16571-245_c7336946-9638-4837-9046-1aef77694672", "dosage_form": "CAPSULE", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "16571-245", "generic_name": "Itraconazole", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Itraconazole", "active_ingredients": [{"name": "ITRACONAZOLE", "strength": "100 mg/1"}], "application_number": "ANDA205724", "marketing_category": "ANDA", "marketing_start_date": "20250203", "listing_expiration_date": "20261231"}